Pink Sheet Podcast: Pharma Gets Democratic Senate, Slow COVID-19 Vaccinations, 2020 CDER Approvals
Source : 'The Pink Sheet'
Pink Sheet senior writers Derrick Gingery and Sarah Karlin-Smith, Executive Editor Nielsen Hobbs and Senior Editor Cathy Kelly discuss the potential effects of the now Democrat-controlled Senate on pharma following the Georgia run-off elections, ongoing problems ramping up coronavirus vaccinations, and the Center for Drug Evaluation and Research’s 2020 novel drug and biologic approval count.
Capitol Hill Riot Draws Manufacturing Group’s Call For Trump’s Removal
Operation Warp Speed’s Difficult Holiday Season
US FDA 2020 Novel Approval Count Rises To 53 At CDER, Plus 5 New CBER Biologics
By Pink Sheet Team